APO 150 (Nizatidine 150 mg)
Pill imprint APO 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; erosive esophagitis; indigestion; duodenal ulcer; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
- 150 mg
- White & Yellow
- Rx and/or OTC
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|55045-3748||Dispensing Solutions Inc. (repackager)|
|55887-0153||Diversified Healthcare Services Inc (repackager)|
|23490-6010||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about nizatidine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.